Discover
DMRA
Damora Therapeutics, Inc.
32.99
1 x 32.35
1 x 33.55
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
32.34 -0.65 (1.97%)
| Ytd | 29.32% | |
| 1y | 29.32% |
31.94
day range
34.75
2.45
52 week range
38.33
| Open | 32.68 | Prev Close | 32.99 | Low | 31.94 | High | 34.75 | Mkt Cap | 2.03B |
| Vol | 436.64K | Avg Vol | 557.50K | EPS | -4.48 | P/E | -7.36 | Forward P/E | -14.82 |
| Beta | 1.46 | Short Ratio | 3.49 | Inst. Own | 91.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 25.15 | 200-d Avg | 23.00 | 1yr Est | 43.38 |
DMRA News
benzinga.com
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Ma
US stock futures up, Nasdaq 100 gains 1%. Danaher Corp (DHR) shares fall 10.1% in pre-market trading
globenewswire.com
Damora Announces Redomestication from Delaware to Cayman Islands
BOSTON, July 17, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (Damora or the Company) (NASDAQ:
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session